Therapeutic effectiveness of an antibody against brevetoxin (PbTx-2)

Toxicon ◽  
1989 ◽  
Vol 27 (1) ◽  
pp. 82
2011 ◽  
Vol 73 (3) ◽  
pp. 260-265
Author(s):  
Toshinori BITO ◽  
Shun OHMORI ◽  
Mayuko YOSHIZAWA ◽  
Sanehito HARUYAMA ◽  
Yu SAWADA ◽  
...  

2020 ◽  
Vol 27 (1) ◽  
pp. 154-169 ◽  
Author(s):  
Claudiu N. Lungu ◽  
Bogdan Ionel Bratanovici ◽  
Maria Mirabela Grigore ◽  
Vasilichia Antoci ◽  
Ionel I. Mangalagiu

Lack of specificity and subsequent therapeutic effectiveness of antimicrobial and antitumoral drugs is a common difficulty in therapy. The aim of this study is to investigate, both by experimental and computational methods, the antitumoral and antimicrobial properties of a series of synthesized imidazole-pyridine derivatives. Interaction with three targets was discussed: Dickerson-Drew dodecamer (PDB id 2ADU), G-quadruplex DNA string (PDB id 2F8U) and DNA strain in complex with dioxygenase (PDB id 3S5A). Docking energies were computed and represented graphically. On them, a QSAR model was developed in order to further investigate the structure-activity relationship. Results showed that synthesized compounds have antitumoral and antimicrobial properties. Computational results agreed with the experimental data.


2020 ◽  
Vol 318 (5) ◽  
pp. H1325-H1336
Author(s):  
Jaime Eugenín ◽  
Carolina Larraín ◽  
Patricio Zapata

Unilateral carotid body denervation has been proposed as treatment for sympathetic hyperactivity-related human disorders. Its therapeutic effectiveness for maintaining a persistent decrease in the sympathetic outflow activity will depend on the absence of compensatory chemoreflex plasticity in the remnant carotid and aortic afferents. Here, we suggest that the integrity of central afferents after carotid body denervation is essential to prevent the emergence of plastic functional changes on the contralateral “intact” carotid nerve.


2021 ◽  
Vol 9 (6) ◽  
Author(s):  
So Shimamura ◽  
Masafumi Saiki ◽  
Shuichiro Ide ◽  
Kazuki Masuda ◽  
Yoshinori Uchida ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Golnar Rahimzadeh ◽  
Majid Saeedi ◽  
Mahmood Moosazadeh ◽  
Seyyed Mohammad Hassan Hashemi ◽  
Amirhossein Babaei ◽  
...  

AbstractThe therapeutic effectiveness of a chitosan encapsulated bacteriophage cocktail as a smart biocontrol agent was evaluated in this study to be used as a preventative and treatment option for gastrointestinal infections. To evaluate the effect of the bacteriophage formulation on the treatment of gastrointestinal infection, rats were infected with Salmonella enterica, Shigella flexneri, and Escherichia coli. The rats were weighed and their stools cultured. The results showed that the group which had the chitosan encapsulated bacteriophage cocktail did not lose weight after 3 days and had significantly lower group weight changes. Weight loss was significant in the rats that had cefixime administered instead. Positive cultured stools were reduced after 4 days compared to 2 days in the treated group with the chitosan encapsulated bacteriophage cocktail. The chitosan encapsulated bacteriophage cocktail can therefore be effective in the treatment of gastrointestinal infections.


Sign in / Sign up

Export Citation Format

Share Document